This review will aim to look at the benefits and harms of instituting antithrombotic therapy to patients undergoing solid organ transplantation.
This is a protocol.
Interventions for preventing thrombosis in solid organ transplant recipients
You may also be interested in:
- Which drugs are most effective to prevent tuberculosis in organ transplant recipients?
- Antiviral drugs used as protective and preventive therapy reduce CMV disease and CMV-associated deaths in solid organ transplant recipients
- Prophylaxis with Immunoglobulin G (IgG), anti CMV vaccine or interferon do not significantly reduce CMV disease and CMV-associated mortality in solid organ transplant recipients
- Cardiac testing for coronary artery disease in potential kidney transplant recipients
- Routine prophylactic stenting reduces the incidence of major urological complications in kidney transplant recipients
Health topics: